Is the active ingredient.
Adjunctive therapy for partial seizures (with or without secondary generalization) in adults and children aged 6 years and older.
Treatment of LennoxGastaut syndrome in adults and children aged 6 years and older.
Zonisep 25mg Cap (Zonisamide)'s exact mechanism isn't fully understood, but it's believed to work by blocking sodium channels, inhibiting calcium channels, and potentially affecting the release of excitatory neurotransmitters in the brain. This helps to reduce the abnormal electrical activity responsible for seizures.
Store at room temperature (20°C to 25°C). Protect from moisture.
Dosage is determined by a physician and should be adjusted based on individual needs and response. It's typically started at a low dose and gradually increased.
It is usually taken orally, with or without food.
Do not crush, chew, or break the tablets.
Drowsiness
Dizziness
Headache
Fatigue
Nausea
Weight loss
Kidney stones (rare but serious)
Metabolic acidosis (rare but serious)
Skin rash
Cognitive impairment (rare)
Alcohol should be avoided or consumed in moderation while taking zonisamide, as it can increase the risk of drowsiness and other side effects.
Avoid driving or operating machinery until you know how zonisamide affects you, as drowsiness and dizziness are potential side effects.
Inform your doctor immediately if you are pregnant, planning to become pregnant, or breastfeeding. Zonisamide should only be used during pregnancy if the benefits outweigh the risks. It can pass into breast milk.
Zonisamide is approved for use in children aged 6 and older, but dosage adjustments are necessary.
Zonisamide can affect kidney function, and those with pre-existing kidney problems should be monitored closely. Dosage adjustments may be needed.
Liver function should be monitored, especially in individuals with pre-existing liver conditions. Zonisamide may rarely affect liver function.
Please consult your physician or refer to the official drug monograph for detailed information.
